#036: Oct 25th, 2021 - Longevity Marketcap Telemetry

1. Announcements

2. Last Week(s) in Longevity

3. Longevity Futures

4. Capital Raise Radar

5. Longevity Jobs

6. New Companies on Longevity List 

7. Special Note: The Last Generation to Die

8. Media is Code.

9. My Links

*Sincerest apologies to my readers: I’ve been focussing 100% of my efforts on launching the first cohort of the On Deck Longevity Biotech (ODLB) program. Going forward, expect a more regular cadence for the Longevity Marketcap Newsletter. Thank you for your patience!

*Disclaimer: None of this should be taken as financial advice. It is for educational purposes only.

Mission: To grow a wave of passionate people building, funding, and championing technologies that extend healthy human lifespan. 

If you want to be part of this mission alongside me, please consider supporting through Patreon or Longevity List Merch.

📢 Announcements 

• The On Deck Longevity Biotech Team (Ada Nguyen, Michelle Kwok, and myself) successfully launched the first cohort of ODLB on September 12th. Thank you to everyone who supported us and our mission: To increase the number of people working to build longevity biotech startups

  • Interested in getting involved in the Longevity Biotech startup ecosystem as a founder, early hire, or investor? Apply for the waiting list for the 2nd cohort of On Deck Longevity Biotech.

• On Deck announces ODX, a $100M accelerator fund. I’m excited to be part of On Deck’s newest initiative to support founders with the launch of ODX. Any early-stage founders looking to get capital, support, and backing from an incredible community should apply -- especially if you are a longevity biotech founder!
  

• My longevity rolling fund Healthspan Capital is now public on Angel List. We aim to invest in a broad “index-like” manner in longevity biotech startups.  

  • Sebastian Brunemeier (former Principal at Apollo Health Ventures, co-founder of Cambrian Biopharma) is an advisor.

  • Michael Chinen (angel investor) is a partner.

  • Any accredited investor can start investing in the fund today. Minimum check size is $5k.

  • Select investment deals will be syndicated.

• Proud to announce that I’ve recently become an angel investor in Transistor Bio, a startup founded by the unrelenting Adam Ashwal. Transistor Bio is building a platform to automate in vivo studies, with a particular focus on dramatically lowering the cost of aged mice (which cost half their weight in gold).

• Notice to new readers: You might want to take a look at this post of longevity resources if